Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Nurix Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +4 vs. Q2 2023
- Shares held
- 44.8M
- +2.11M (+5.0%) vs. Q2 2023
- Total value
- $352.5M
- −$73.9M (−17.3%) vs. Q2 2023
- New holders
- 14
- 41 more added
- Sold out
- 10
- 51 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 253,413 | $1.99M | 0.00% | +44,316+21.2% | Added |
| Suvretta Capital Management, LLC | 280,760 | $2.21M | 0.12% | 00.0% | Unchanged |
| WestHill Financial Advisors, Inc. | 283,333 | $2.23M | 0.65% | 00.0% | Unchanged |
| Millennium Management LLC | 288,157 | $2.26M | 0.00% | −356,254−55.3% | Reduced |
| ArrowMark Colorado Holdings LLC | 314,762 | $2.47M | 0.03% | +314,762 | New |
| FMR LLC | 320,907 | $2.52M | 0.00% | −95,706−23.0% | Reduced |
| Bessemer Group Inc | 357,287 | $2.81M | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 363,526 | $2.86M | 0.00% | +40,878+12.7% | Added |
| Northern Trust Corp | 440,852 | $3.47M | 0.00% | +12,210+2.8% | Added |
| Bank of America Corp | 546,450 | $4.30M | 0.00% | −41,575−7.1% | Reduced |
| DAFNA Capital Management LLC | 556,695 | $4.38M | 1.36% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 568,576 | $4.47M | 0.00% | +184,617+48.1% | Added |
| Nuveen Asset Management, LLC | 663,260 | $5.21M | 0.00% | −4,157−0.6% | Reduced |
| Soleus Capital Management, L.P. | 814,000 | $6.40M | 0.64% | +814,000 | New |
| Pictet Asset Management Holding SA | 897,809 | $7.06M | 0.01% | +897,809 | New |
| Dimensional Fund Advisors LP | 958,043 | $7.53M | 0.00% | +180,531+23.2% | Added |
| Candriam Luxembourg S.C.A. | 968,110 | $7.61M | 0.06% | −51,712−5.1% | Reduced |
| Geode Capital Management, LLC | 1,045,285 | $8.22M | 0.00% | +67,234+6.9% | Added |
| Boxer Capital, LLC | 1,224,892 | $9.63M | 0.51% | 00.0% | Unchanged |
| State Street Corp | 1,774,068 | $13.9M | 0.00% | −151,658−7.9% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14.3M | 1.60% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,377,978 | $18.7M | 0.00% | −1,895−0.1% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,593,047 | $20.4M | 0.16% | +331,976+14.7% | Added |
| Vanguard Group Inc | 2,714,845 | $21.3M | 0.00% | +22,804+0.8% | Added |
| Redmile Group, LLC | 2,848,827 | $22.4M | 1.07% | −8,482−0.3% | Reduced |
| Deep Track Capital, LP | 2,997,830 | $23.6M | 0.91% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 3,564,616 | $28.0M | 0.18% | −305,159−7.9% | Reduced |
| Baker Bros. Advisors LP | 3,882,125 | $30.5M | 0.18% | 00.0% | Unchanged |
| BlackRock Inc. | 4,518,554 | $35.5M | 0.00% | −8230.0% | Reduced |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −314,762−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −130,040−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −62,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,432−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −16,025−100.0% | Sold out |
| Innovis Asset Management LLC | 0 | $0 | 0.00% | −15,648−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −14,239−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −12,991−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −10,783−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |